Principal Activity
The development of novel antisense pharmaceuticals for commercially important human conditions.
ANP - ANTISENSE THERAPEUTICS LIMITEDORDINARY FULLY PAID
| Price | Change | Last updated |
|---|---|---|
| 0.045 | 0.000(0.00%) |
| Open | 0.000 |
|---|---|
| High | 0.000 |
| Low | 0.000 |
| Prev close | 0.045 |
| Vol | 0 |
| Val ($A) | 0 |
| Prev Close | 0.045 | Volume | 0 |
|---|---|---|---|
| Bid | 0.045 | Average Volume | 282,390 |
| Ask | 0.046 | Value ($A) | 0 |
| 52-wk High | 0.125 | P/E | 8.65 |
| 52-wk Low | 0.032 | Div/Share | 0.0000 |
| EPS | 0.01 | Div Yield | 0.0% |
| Earnings Yield | 11.56% | Status | - |
Company Profile
| Market Cap | 7,943,062 | Sector | Health Care (35) |
|---|---|---|---|
| Issued Shares | 176,512,483 | Industry Group | Pharmaceuticals, Biotechnology & Life Sciences (3520) |
| First Listed | 20 Dec 2001 | Security Type | Ordinary (1) |
| First Traded | 06 Dec 2001 |
Trading Summary
| Trades | Volume | Value | High | Low | |
|---|---|---|---|---|---|
| Today | 0 | 0 | 0 | 0.000 | 0.000 |
| This Week | 15 | 333,676 | 15,489 | 0.050 | 0.043 |
| This Month | 180 | 5,416,080 | 256,510 | 0.060 | 0.034 |
| This Year | 515 | 16,190,746 | 772,278 | 0.071 | 0.032 |
| Rolling Year | 1,260 | 36,162,699 | 2,584,212 | 0.125 | 0.032 |
